
First Metatarsal Bone Mass
Case Studies provide an interactive distance-learning experience to interesting cases in the field of cytopathology. Each Case includes objectives, images, a clinical history, along with a multiple-choice diagnosis followed by discussion, review images and references.
Target Audience
This educational activity is designed for pathologists, fellows/residents, cytotechnologists, and other members of the cytopathology community.
Learning Objectives
- Describe cytomorphologic features of giant cell tumor of bone
- Distinguish giant cell tumor of bone from other giant cell-rich lesions
- Describe the utility of immunohistochemistry markers for giant cell tumor of bone and other giant cell-rich lesions
Presenting Authors:
Priti Agarwal, MD, MHS
Mohamed Alhamar, MD
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.
The following individuals have reported financial relationships:
Christopher J. VandenBussche, MD, PhD: Scientific Advisor Board (stock options) - AlxMed, Inc.
The following individuals have reported no relevant financial relationships:
Omar Al-Nourhji, MD, Kristen Atkins, MD, Catherine Bammert, PhD, CT, MB(ASCP), Christine Booth, MD, Tamar Brandler, MD, MS, Amy Clayton, MD, Jacqueline Cuda, BS, SCT(ASCP), Fang Fan, MD, PhD, Beverly Haigler-Daly, BS, CT(ASCP), Michael Henry, MD, Raza Hoda, MD, Yanjun Hou, MD, PhD, Lucy Jager, MD, Samer Khader, MD, Melanie Kwan MD, Zaibo Li, MD, PhD, Xiaoying Liu, MD, Sean McNair, MPH, CT(ASCP), Sara Monaco, MD, Michiya Nishino, MD, PhD, Milissa Randolph, BS, SCT(ASCP), Erika Rodriguez, MD, PhD, Michelle Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin Siddiqui, MD, Teri Stewart, MS, CT(ASCP)CM, Brittney Thiele, MD, Michael Thrall, MD, Qun Wang, MD, PhD, Vivian Weiss, MD, PhD, Ashley Zucker, MS, CT(ASCP), Priti Agarwal, MD, MHS, Mohamed Alhamar, MD
The ASC staff associated with the development of content for this activity reported no relevant financial relationships.
Credits and Accreditation
Continuing Medical Education (CME)
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Continuing Certification (CC) process. Earn up to 1.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 1.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytologists with Licenses in Florida and California
This program is approved for 1 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 1.00 CMLE
- 1.00 Florida Credits
- 1.00 Participant